Matthew Pediaditis

Dr. Matthew Pediaditis

Foundation for Research and Technology, Hellas, Greece

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in IEEE Transactions on Affective Computing
Verified
Journal Article
Open access
APAnastasia Pampouchidou
Anastasia Pampouchidou
PSPanagiotis Simos
Panagiotis Simos
Kostas MariasKostas Marias
Kostas Marias
fabrice meriaudeaufabrice meriaudeau
fabrice meriaudeau
Fan YangFan Yang
Fan Yang
Manolis TsiknakisManolis Tsiknakis
Manolis Tsiknakis
Automatic depression assessment based on visual cues is a rapidly growing research domain. The present exhaustive review of existing approaches as reported in over sixty publications during the last ten years focuses on image processing and machine learning algorithms. Visual manifestations of depression, various procedures used for data collection, and existing datasets are summarized. The review outlines methods and algorithms for visual feature extraction, dimensionality reduction, decision methods for classification and regression approaches, as well as different fusion strategies. A quantitative meta-analysis of reported results, relying on performance metrics robust to chance, is included, identifying general trends and key unresolved issues to be considered in future studies of automatic depression assessment utilizing visual cues alone or in combination with vocal or verbal cues.

1 December 2012 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
Matthew PediaditisMatthew Pediaditis
Matthew Pediaditis
Manolis TsiknakisManolis Tsiknakis
Manolis Tsiknakis
NLNorbert Leitgeb
Norbert Leitgeb

20 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Marios SpanakisMarios Spanakis
Marios Spanakis
ETEleftheria Tzamali
Eleftheria Tzamali
GTGeorgios Tzedakis
Georgios Tzedakis
CKChryssalenia Koumpouzi
Chryssalenia Koumpouzi
Matthew PediaditisMatthew Pediaditis
Matthew Pediaditis
Vangelis SakkalisVangelis Sakkalis
Vangelis Sakkalis
Artificial intelligence (AI) has emerged as a powerful tool in medical sciences that is revolutionizing various fields of drug research. AI algorithms can analyze large-scale biological data and identify molecular targets and pathways advancing pharmacological knowledge. An especially promising area is the assessment of drug interactions. The AI analysis of large datasets, such as drugs’ chemical structure, pharmacological properties, molecular pathways, and known interaction patterns, can provide mechanistic insights and identify potential associations by integrating all this complex information and returning potential risks associated with these interactions. In this context, an area where AI may prove valuable is in the assessment of the underlying mechanisms of drug interactions with natural products (i.e., herbs) that are used as dietary supplements. These products pose a challenging problem since they are complex mixtures of constituents with diverse and limited information regarding their pharmacological properties, especially their pharmacokinetic data. As the use of herbal products and supplements continues to grow, it becomes increasingly important to understand the potential interactions between them and conventional drugs and the associated adverse drug reactions. This review will discuss AI approaches and how they can be exploited in providing valuable mechanistic insights regarding the prediction of interactions between drugs and herbs, and their potential exploitation in experimental validation or clinical utilization.

1 August 2012
Verified
Conference Paper
Closed access
Matthew PediaditisMatthew Pediaditis
Matthew Pediaditis
MTM. Tsiknakis
M. Tsiknakis
Lefteris KoumakisLefteris Koumakis
Lefteris Koumakis
MKM. Karachaliou
M. Karachaliou
SVS. Voutoufianakis
S. Voutoufianakis
PVP. Vorgia
P. Vorgia
In order to diagnose epilepsy, neurologists rely on their experience, performing an equal assessment of the electroencephalogram and the clinical image. Since misdiagnosis reaches a rate of 30% and more than one-third of all epilepsies are poorly understood, a need for leveraging diagnostic precision is obvious. With the aim at enhancing the clinical image assessment procedure, this paper evaluates the suitability of certain facial expression features for detecting and quantifying absence seizures. These features are extracted by means of time-varying signal analysis from signals that are gained by applying computer vision techniques, such as face detection, dense optical flow computation and averaging background subtraction. For the evaluation, video sequences of four patients with absence seizures are used. The classification performance of a C4.5 decision tree shows accuracies of up to 99.96% with a worst percentage of incorrectly classified instances of 0.14%.